Neurofeedback may reduce chemotherapy-induced neuropathy

Written by Alice Weatherston

In a study that will be presented at the upcoming American Psychosomatic Society annual meeting (9–12 March 2016; Denver, CO, USA), a team of researchers at The University of Texas MD Anderson Cancer Center (TX, USA) have discovered a link between the use of neurofeedback and a decrease in personal experience of chronic pain in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN). The results help to expand knowledge of neuropathic pain and a chemotherapy side effect that affects 71–96% of cancer patients. “Chemotherapy-induced peripheral neuropathy is very common in cancer patients and there is currently only one medication approved to...

To view the full article, please register now for access

It's completely free